Angelus welcomes Temporary ban on Gogaine, other substances

NewsGuard 100/100 Score

The only UK charity dedicated to raising awareness of the risks from 'legal highs', the Angelus Foundation, has announced it welcomes the Temporary ban on Gogaine and other substances. Headshops and internet suppliers are being forced to eradicate their stock of various legal stimulants before midnight tonight. The products affected by this ban include Gogaine, Psyclone, El Blanco, Ching and Burst.

Angelus has long been calling for a fundamental legal change to disrupt the supply of these legal drugs. The Government is now committed to bringing in the necessary law "at the earliest opportunity" but that may be some months away. Angelus supports a greater commitment from schools and universities to ensure young people get the education they need to stay safe from these substances often called 'legal highs'.

Chief Executive of Angelus, Jan King said, "The harms from these stimulants, like Gogaine, have been shown to be very significant. So naturally we welcome the Temporary Ban, which will force headshops to immediately clear their shelves of these harmful products. But a Temporary Ban is just that and we need the next Government to introduce, as a priority, more comprehensive legislation to kill off the high street trade in legal drugs. Easy access to these 'legal highs' leads to dangerous experimentation by teenagers and addiction among vulnerable groups like the homeless. Angelus will continue to raise awareness of the risks to young people but we need local authorities, schools and universities to play their part too."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Treating gum disease during AFib blanking period could reduce recurrence risk